REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026

For research purposes only. Full disclaimer →

Research Library

749 papers · 61 analysis articles

Research Analysis

Curated deep-dives into the latest peptide research

Papers Database

Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials.

Badran Ahmed Samy et al.Obesity research & clinical practice2026
pubmedMeta-Analysis

Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options.

Toledo Rafaela Germano et al.Journal of minimally invasive gynecology2026
pubmedMeta-Analysis

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis.

Karakasis Paschalis et al.Metabolism: clinical and experimental2025
pubmedMeta-Analysis

Efficacy and safety of GLP-1 agonists in the treatment of T2DM: A systematic review and network meta-analysis.

Ren Xiaoyu et al.Scientific reports2025
pubmedMeta-Analysis

Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis.

Tian Yong et al.Frontiers in immunology2025
pubmedMeta-AnalysisHumanHigh QualityThymosin alpha 1Tα1

Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA.

Sinha Binayak et al.Obesity (Silver Spring, Md.)2025
pubmedMeta-AnalysisHumanHigh QualityGLP-1 receptor agonistsdual agonists

Efficacy and safety of triple hormone receptor agonist retatrutide for the management of obesity: a systematic review and meta-analysis.

Tewari Jay et al.Expert review of clinical pharmacology2025
pubmedMeta-AnalysisHumanHigh Qualityretatrutidetriple hormone receptor agonist

Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials.

Xie Zeyu et al.Metabolism: clinical and experimental2024
pubmedMeta-Analysis

Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

Cao Ailing et al.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2024
pubmedMeta-AnalysisHumanHigh QualityThymosin alpha 1

Medications for Obesity: A Review.

Gudzune Kimberly A et al.JAMA2024
pubmedMeta-AnalysisHumanHigh Qualityliraglutidesemaglutide

Glucagon-Like Peptide 1 Analogues as Adjunctive Therapy for Patients With Type 1 Diabetes: An Updated Systematic Review and Meta-analysis.

Park Jeayoung et al.The Journal of clinical endocrinology and metabolism2023
pubmedMeta-Analysis

Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.

Karagiannis Thomas et al.Diabetologia2022
pubmedMeta-Analysis

Metformin: Is it a drug for all reasons and diseases?

Triggle Chris R et al.Metabolism: clinical and experimental2022
pubmedMeta-AnalysisHumanHigh QualityMetforminmTOR inhibition

Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in Women.

Spielmans Glen IJournal of sex research2021
pubmedMeta-Analysis

The Systematic Review and Meta-Analysis on the Immunogenicity and Safety of the Tuberculosis Subunit Vaccines M72/AS01

Ullah Inayat et al.Frontiers in immunology2020
pubmedMeta-Analysis

Female Sexual Dysfunction and the Placebo Effect: A Meta-analysis.

Weinberger James M et al.Obstetrics and gynecology2018
pubmedMeta-Analysis